Filter
1318
Filtered Results: 1318
Text search:
drug
susceptibility
Featured
Recommendations
161
New Publications
312
Language
Document type
No document type
717
Guidelines
230
Studies & Reports
224
Manuals
60
Strategic & Response Plan
41
Fact sheets
20
Training Material
14
Situation Updates
10
Online Courses
2
Countries / Regions
India
63
Western and Central Europe
44
Ethiopia
32
Eastern Europe
31
Kenya
30
Latin America and the Carribbean
30
South Africa
25
Global
24
Tanzania
21
Africa
20
Nepal
18
Nigeria
18
Zambia
18
Bangladesh
16
Uganda
15
Malawi
14
Philippines
14
Rwanda
12
Ghana
11
Peru
11
Zimbabwe
10
Asia
10
South–East Asia Region
10
Liberia
10
Colombia
9
Sierra Leone
9
Ukraine
8
Mozambique
8
Cambodia
8
Argentina
7
Lesotho
6
Brazil
6
Russia
6
Namibia
6
Myanmar / Burma
6
Eswatini/ Swaziland
6
Germany
5
Western Pacific Region
5
Bolivia
5
Botswana
5
Pakistan
5
Tajikistan
4
El Salvador
4
Cameroon
4
Senegal
4
Venezuela
4
Spain
4
Syria
3
Albania
3
Laos
3
Burkina Faso
3
USA
3
Congo, Democratic Republic of
3
North America
3
Uruguay
3
Lebanon
3
Vietnam
3
Sudan
3
Thailand
2
Turkey
2
Chile
2
Fiji
2
Afghanistan
2
Morocco
2
Armenia
2
Guinea-Bissau
2
Jordan
2
Saudi Arabia
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Paraguay
2
Gabon
2
United Kingdom
2
Georgia
2
Angola
2
Bhutan
2
Indonesia
2
Iraq
2
Ecuador
2
North Macedonia
1
Timor Leste/ East Timor
1
Mexico
1
Benin
1
Gambia
1
China
1
Iran
1
Qatar
1
Haiti
1
Ireland
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Portugal
1
East and Southern Africa
1
Papua New Guinea
1
Nicaragua
1
Sri Lanka
1
Greece
1
Honduras
1
Mali
1
Libya
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
414
Clinical Guidelines
167
Public Health
67
Women & Child Health
28
Key Resources
25
Pharmacy & Technologies
22
Capacity Building
17
Toolboxes
TB
382
AMR
198
HIV
101
NTDs
59
COVID-19
49
Mental Health
41
Rapid Response
40
Planetary Health
25
Pharmacy
20
Refugee
15
Ebola & Marburg
15
Global Health Education
14
Caregiver
12
NCDs
11
Polio
11
Cholera
10
Natural Hazards
8
Conflict
7
Specific Hazards
6
Malaria
5
Disability
4
Zika
3
WHO-2019-nCoV-genomic_sequencing
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets trends in biosafety.
LBM encouraged countries t...
A global Review of evidence and practice
The Infection Prevention and Control (IPC) Assessment Framework (IPCAF) is a tool to support the implementation of the World Health Organization (WHO) Guidelines on core components of IPC programmes at the acute health care facility level. The user should be familiar with the contents of these guide...
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve...
In order to maintain daily operations and patient care services, health care facilities need to develop an Emergency Water Supply Plan (EWSP) to prepare for, respond to, and recover from a total or partial interruption of the facilities’ normal water supply. Water supply interruption can be caused...
SADJ August 2016, Vol 71 no 7 p314 - p318
Clinical Review
This study, and similar studies in Kenya, Mozambique, Swaziland, Uganda, and Zambia is the outcome of close collaborative by a team in Swaziland, with technical and financial support from the UNAIDS Regional Support Team for Eastern and Southern Africa, UNAIDS Geneva, and the World Bank's Global HIV...
A regional guide for governments in Asia and the Pacific to review, update and develop policies to address antimicrobial resistance and antimicrobial use in animal production
With this quick reference guide, providers can easily recognize diseases and side effects related to climate change, implement appropriate management and provide guidance to exposed populations, provide up-to-date information on the relationship between the adverse effects of certain drugs and the w...
Countries around the world are facing the challenge of increased demand for care of people with COVID-19, compounded by fear, misinformation and limitations on movement that disrupt the delivery of health care for all conditions. Maintaining essential health services: operational guidance for the CO...
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Central Africa, where access to proper health care is lim...
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base...
La carga de la diabetes es enorme, posicionándola como uno de los principales desafíos que enfrenta la salud pública en la actualidad. Actualmente, se estima que 62 millones de personas viven con diabetes en la Región de las Américas y las proyecciones muestran que su prevalencia seguirá aumen...
This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy ...
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to ...
